SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (284)10/18/2001 3:36:24 PM
From: scaram(o)uche   of 724
 
>> Anthrax scares spread across the world on Thursday <<

Message 16525118

1. Sales should remain strong for the foreseeable future, IMO.

2. Increased sales due to "bioterrorism" won't be in this next quarterly, but we'll see the effects of the restructure.

3. The restructure, as some of us have discussed, may support about $15/share at a PE of 20.

4. Any progress at DGI, and we go sky high IMO. But given this management team (NBSC), who knows what could be done to screw it up?

5. Still a roach trap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News